Found: 143
Select item for more details and to access through your institution.
Regulation of cell division and of tyrosinase in B16 melanoma cells by imidazole: A possible role for the concept of metabolite Gene regulation in mammalian cells.
- Published in:
- Journal of Cellular Physiology, 1981, v. 106, n. 2, p. 283, doi. 10.1002/jcp.1041060215
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03154-6
- By:
- Publication type:
- Article
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32208-0
- By:
- Publication type:
- Article
HIV-1: nature's master of disguise.
- Published in:
- Nature Medicine, 2003, v. 9, n. 4, p. 393, doi. 10.1038/nm0403-393
- By:
- Publication type:
- Article
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.
- Published in:
- Nature Medicine, 1999, v. 5, n. 5, p. 526, doi. 10.1038/8406
- By:
- Publication type:
- Article
Complement-Mediated Enhancement of HIV-1 Infection Reverses the Anti-HIV-1 Activity of Castanospermine.
- Published in:
- Annals of the New York Academy of Sciences, 1991, v. 616, n. 1, p. 572, doi. 10.1111/j.1749-6632.1990.tb17897.x
- By:
- Publication type:
- Article
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4 + T-Cells.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1662, doi. 10.3390/vaccines11111662
- By:
- Publication type:
- Article
Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Naïve and Convalescent BNT162b2 Recipients.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1904, doi. 10.3390/vaccines10111904
- By:
- Publication type:
- Article
Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 774, doi. 10.3390/vaccines9070774
- By:
- Publication type:
- Article
CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 284, doi. 10.3390/vaccines8020284
- By:
- Publication type:
- Article
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.939627
- By:
- Publication type:
- Article
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.788619
- By:
- Publication type:
- Article
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.670561
- By:
- Publication type:
- Article
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Neutralizing antibodies take a swipe at HIV in vivo.
- Published in:
- Nature Medicine, 2005, v. 11, n. 6, p. 593, doi. 10.1038/nm0605-593
- By:
- Publication type:
- Article
High-Dose Recombinant Canarypox Vaccine Expressing HIV-1 Protein, in Seronegative Human Subjects.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 7, p. 1249
- By:
- Publication type:
- Article
Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV-1 gp120 Vaccines.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 11, p. 1962
- By:
- Publication type:
- Article
Complete Protection of Neonatal Rhesus Macaques against Oral Exposure to Pathogenic Simian-Human Immunodeficiency Virus by Human Anti-HIV Monoclonal Antibodies.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 12, p. 2167, doi. 10.1086/420833
- By:
- Publication type:
- Article
Heterologous Neutralizing Antibody Induction in a Simian-Human Immunodeficiency Virus Primate Model: Lack of Original Antigenic Sin.
- Published in:
- Journal of Infectious Diseases, 2001, v. 184, n. 12, p. 1603, doi. 10.1086/324582
- By:
- Publication type:
- Article
Neutralization Escape in Human Immunodeficiency Virus Type 1- Infected Long-Term Nonprogessors.
- Published in:
- Journal of Infectious Diseases, 1999, v. 179, n. 5, p. 1264, doi. 10.1086/314711
- By:
- Publication type:
- Article
Passive Immunization of Newborn Rhesus Macaques Prevents Oral Simian Immunodeficiency Virus Infection.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 5, p. 1247
- By:
- Publication type:
- Article
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 310, doi. 10.1086/514209
- By:
- Publication type:
- Article
Neutralization Assays using the BZ167 Strain of Human Immunodeficiency Virus Type 1.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 5, p. 1410
- By:
- Publication type:
- Article
Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long-Term-Nonprogressive Infection.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 4, p. 924
- By:
- Publication type:
- Article
Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Binding of Human Immunodeficiency Virus Type I to the C3b/C4b Receptor CRt (CD35) and Red Blood Cells in the Presence of Envelope-Specific Antibodies and Complement.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 2, p. 429, doi. 10.1093/infdis/170.2.429
- By:
- Publication type:
- Article
Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 1992, v. 166, n. 2, p. 244, doi. 10.1093/infdis/166.2.244
- By:
- Publication type:
- Article
LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays.
- Published in:
- BMC Immunology, 2011, v. 12, n. 1, p. 33, doi. 10.1186/1471-2172-12-33
- By:
- Publication type:
- Article
Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.
- Published in:
- Scientific Reports, 2017, p. 46308, doi. 10.1038/srep46308
- By:
- Publication type:
- Article
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43384-y
- By:
- Publication type:
- Article
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38892-w
- By:
- Publication type:
- Article
Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128562
- By:
- Publication type:
- Article
Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128823
- By:
- Publication type:
- Article
Transmitted/Founder Simian Immunodeficiency Virus Envelope Sequences in Vesicular Stomatitis and Semliki Forest Virus Vector Immunized Rhesus Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109678
- By:
- Publication type:
- Article
DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091550
- By:
- Publication type:
- Article
Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082380
- By:
- Publication type:
- Article
Detection of HIV-1 Neutralizing Antibodies in a Human CD4<sup>+</sup>/CXCR4<sup>+</sup>/CCR5<sup>+</sup> T-Lymphoblastoid Cell Assay System.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0077756
- By:
- Publication type:
- Article
Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0076104
- By:
- Publication type:
- Article
Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0078521
- By:
- Publication type:
- Article
Comparison of Systemic and Mucosal Immunization with Helper-Dependent Adenoviruses for Vaccination against Mucosal Challenge with SHIV.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0067574
- By:
- Publication type:
- Article
An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051715
- By:
- Publication type:
- Article
Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038943
- By:
- Publication type:
- Article
9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035356
- By:
- Publication type:
- Article
Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035083
- By:
- Publication type:
- Article
The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0029454
- By:
- Publication type:
- Article
Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8<sup>+</sup> T Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031464
- By:
- Publication type:
- Article
International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0030963
- By:
- Publication type:
- Article
Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024517
- By:
- Publication type:
- Article